Advances in Chronic Kidney Disease
Volume 12, Issue 1 , Pages 84-87, January 2005

Deprivation and dialysis: Pathways to kidney failure in Australian Aborigines

  • Mark Thomas

      Affiliations

    • Department of Nephrology, Royal Perth Hospital, Perth, Australia.
    • Corresponding Author InformationAddress correspondence to Mark Thomas, MB, BS, FRACP, Department of Nephrology, Royal Perth Hospital, Box X2213, Perth, Western Australia 6001.

Rates of end-stage renal disease among Australian Aboriginal people have been increasing over the past 2 decades, particularly in the northern and more remote areas of Australia, and especially in disadvantaged communities. Proteinuria predicts the rate of loss of kidney function; it is common in young adults and virtually universal in those over 50 years of age. Cumulative independent risk factors include low birth weight, recurrent skin infections, adult obesity, diabetes or its precursors, smoking, excessive alcohol intake, and a family history of renal disease. A plausible theory is that intrauterine malnutrition permanently reduces total nephron numbers, which are then overworked in adulthood by the metabolic stresses of obesity (from excess alcohol and poor diet), by higher blood pressures, and by infections, while starved of blood supply because of smoking. Although kidney disease is often only detected when already well established, active medical intervention offers great rewards. Control of blood pressure (preferentially using angiotensin-converting enzyme (ACE) inhibitors and angiotensin-II receptor blockers (AIIRBs) in combination) can often stop or even reverse kidney damage, even if ongoing diabetes control is poor. Adequately funded kidney health programs with active Aboriginal health worker involvement are enormously cost-effective: tight blood pressure control at least halves the rate of disease progression, and every year of dialysis deferred for 1 patient could fund the appointment of 2 health workers. Addressing the underlying social causes for this epidemic is critical.

Index words:  Aborigine , end-stage renal disease , proteinuria , birth weight , obesity , diabetes

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr. Thomas has received honoraria for lectures, research funding and conference attendance costs from a number of different pharmaceutical companies, including Amgen Australia, Astra-Zeneca, Boehringer Ingelheim, Fresenius Medical Care, Janssen-Cilag, Novartis, Sanofi-Synthelabo, Servier Laboratories, and Solvay Pharmaceuticals.

PII: S1548-5595(04)00180-6

doi:10.1053/j.ackd.2004.10.008

Advances in Chronic Kidney Disease
Volume 12, Issue 1 , Pages 84-87, January 2005